REDWOOD CITY, Calif., Nov. 21, 2013 (GLOBE NEWSWIRE) -- California based myoscience, inc., developers of the iovera°® system powered by Focused Cold TherapyTM for the treatment of peripheral nerve conditions, announced today that it will be participating in the Piper Jaffray 25th Annual Health Care Conference in New York. Clint Carnell, Chairman and Chief Executive Officer, will discuss myoscience's platform technology using the well-established science of cryoneuromodulation to precisely deliver cold for use in pain management and other peripheral nerve conditions. Mr. Carnell is scheduled to present on December 4, 2013 at 1:30 am ET.
ABOUT MYOSCIENCE
Silicon Valley, California-based myoscience is a privately-held medical device company committed to making its platform technology, Focused Cold Therapy, the standard of care for the treatment of peripheral nerve conditions. Focused Cold Therapy is the patented technology delivered by the iovera° system. The iovera° system is currently approved in Europe and Canada for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions, and is indicated in the United States for use in pain management and general surgical use. For more information, please visit www.myoscience.com.
© 2013 myoscience. All rights reserved. iovera° and Focused Cold Therapy are trademarks of myoscience.